Big Money Sentiment increased to 1.53 in Q2 2018. It has change of 0.18, from 2018Q1’s 1.35. The ratio improved due to ILMN positioning: 26 sold and 175 reduced. 87 funds acquired holdings and 221 increased holdings. Investors holded 129.91 million in 2018Q1 but now own 128.56 million shares or 1.04% less. Jaffetilchin Investment Ptnrs Limited Liability Company accumulated 2,021 shs. Bnp Paribas Asset Mngmt has 0.03% invested in Illumina, Inc. (NASDAQ:ILMN). Wafra accumulated 33,712 shs or 0.35% of the stock. Walter And Keenan Finance Consulting Mi Adv holds 0.8% of its capital in Illumina, Inc. (NASDAQ:ILMN) for 6,650 shs. Victory Capital Mngmt has invested 0.18% in Illumina, Inc. (NASDAQ:ILMN). Nordea Inv Mngmt Ab holds 7,321 shs. Wellington Shields Capital Lc holds 1.06% or 22,992 shs. Wellington Shields Ltd Liability Com has 82,049 shs. Advsrs Asset Mngmt invested in 20,308 shs or 0.2% of the stock. New York-based Arrowgrass Cap Prns (Us) Ltd Partnership has invested 1% in Illumina, Inc. (NASDAQ:ILMN). Hbk Sorce Advisory Lc invested in 0.07% or 2,226 shs. Majedie Asset Management has 2,133 shs for 0.05% of their capital. Endurance Wealth Mgmt Inc holds 0.01% or 250 shs in its capital. National Bank & Trust Of Montreal Can stated it has 0.03% of its capital in Illumina, Inc. (NASDAQ:ILMN). Sigma Planning holds 1,921 shs or 0.04% of its capital.
ILMN had 18 selling transactions and 0 insider buys since May 14, 2018. This’s net activity of $18.04 million. deSouza Francis A sold $564,124 worth of Illumina, Inc. (NASDAQ:ILMN) on Monday, May 14. EASTHAM KARIN also sold $269,802 worth of Illumina, Inc. (NASDAQ:ILMN) on Monday, May 21. On Wednesday, September 12 FLATLEY JAY T had sold 3,300 shs worth $1.16M. $412,364 worth of stock was sold by Stapley Marc on Monday, June 11. EPSTEIN ROBERT S also sold $144,225 worth of Illumina, Inc. (NASDAQ:ILMN) shs. Van Oene Mark sold 1,091 shs worth $386,410.
Tiaa Cref Investment Management Llc’s stake in Illumina Inc (ILMN) is reduced by 6.28% based on its latest 2018Q2 regulatory filing with the SEC. The company’s stock rose 21.79% with the market as Tiaa Cref Investment Management Llc sold 104,962 shares. At the end of 2018Q2, the 1.57 million shares of the capital goods company held by the institutional investor were priced at $437.25M, down from 1.67 million at the end of the previous reported quarter. $48.40B is the market cap of Illumina Inc. ILMN hit $329.25 during the last trading session after $10.3 change.Illumina, Inc. has 1.19M shares volume, 15.31% up from normal. ILMN is uptrending and has moved 63.52% since November 10, 2017. The stock outperformed the S&P 500 by 47.90%.
According to a filing Tiaa Cref Investment Management Llc increased its stake in Praxair Inc (NYSE:PX) by 170,120 shares to 2.03M shares, valued at $320.58M in 2018Q2. The fund manages about $148.79B US Long portfolio. For a total of 184,963 shares it increased its holding in Trex Co Inc (NYSE:TREX) by 94,435 shares in the quarter, and has risen its stake in Boston Scientific Corp (NYSE:BSX).
For more Illumina, Inc. (NASDAQ:ILMN) news released recently go to: Seekingalpha.com, Seekingalpha.com, Fool.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “Illumina Q3 top line up 20%; earnings up 22%; guidance raised” released on October 23, 2018, “Illumina, Inc. (ILMN) CEO Francis deSouza on Q3 2018 Results – Earnings Call Transcript” on October 24, 2018, “3 Growth Stocks Healthcare Investors Should Buy Now” with a publish date: November 09, 2018, “Illumina, Inc. (ILMN) CEO Francis deSouza Hosts Acquisition of Pacific Biosciences Conference (Transcript)” and the last “Pacific Biosciences Bows Out Gracefully” with publication date: November 02, 2018.
Illumina, Inc. (NASDAQ:ILMN) Ratings Coverage
Total analysts of 8 have positions in Illumina (NASDAQ:ILMN) as follows: 7 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 88%. Since May 29, 2018 according to StockzIntelligence Inc Illumina has 13 analyst reports. On Monday, June 25 the company was maintained by Citigroup. In Friday, August 10 report Argus Research maintained the stock with “Buy” rating. On Wednesday, October 24 the stock of Illumina, Inc. (NASDAQ:ILMN) has “Overweight” rating given by Barclays Capital. In Tuesday, July 31 report Canaccord Genuity maintained it with “Buy” rating and $340 target. On Tuesday, August 7 the stock of Illumina, Inc. (NASDAQ:ILMN) has “Equal-Weight” rating given by Morgan Stanley. On Tuesday, July 31 the stock has “Buy” rating by Citigroup. In Tuesday, May 29 report Canaccord Genuity maintained it with “Buy” rating and $29000 target. On Tuesday, July 31 Barclays Capital maintained the shares of ILMN in report with “Overweight” rating. On Tuesday, July 17 the rating was maintained by PiperJaffray with “Overweight”. On Thursday, May 31 the firm has “Underweight” rating given by Morgan Stanley.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.